Financial Trends -- 3/10
MP is mid-transition from a China-dependent concentrate exporter to an integrated NdPr-oxide +
magnet producer. The financials reflect a trough being worked through: revenue is volatile (not
cleanly accelerating), gross margin is recovering off a deep 2024 trough, but GAAP operating income
is negative every quarter and free cash flow is negative and worsening — 2025 was the worst FCF year
on record (-$303.9M). The mandatory negative-FCF penalty caps this dimension at 6, and the
revenue-up / operating-income-down penalty knocks it to 3.
Weight: 25%
Gross Margin
18.1%
Recovering off -32.6% trough | Improving
Free Cash Flow
Negative
13 straight qtrs; -$303.9M 2025 | Worsening
Adj. EBITDA
$36.6M
Q1'26; inflected positive Q4'25 | DoW floor
Quarterly Revenue Trajectory ($K)
Recovery off a trough, not durable acceleration.
YoY rates whipsaw quarter to quarter and two of the last four quarters still printed negative
YoY. The 2023-24 collapse was a price-and-mix story — NdPr prices fell from ~$70/kg to ~$47/kg
and the company curtailed low-margin China concentrate sales. Q1'26 reaccelerated to +49% YoY
on the NdPr / Magnetics ramp: NdPr sales volume nearly doubled to 1,006 MT and NdPr revenue
tripled YoY to $71.1M.
Revenue by Product Line ($K, quarterly)
The mix shift is the story. NdPr oxide/metal revenue
roughly tripled from $24.3M (Q1'25) to $71.1M (Q1'26) while the deliberate wind-down of
low-margin concentrate exports to China took that line from $40.1M in Q1'24 to zero. Magnetics
scaled from a $5.2M standing start to a ~$20M/quarter run-rate as first commercial-scale magnets
were produced.
Operating KPIs (volume)
The DoW price floor drove the Q4'25/Q1'26 EBITDA inflection.
Materials segment adjusted EBITDA swung from double-digit-million losses to +$40.3M (Q4'25) and
+$36.7M (Q1'26) as the $110/kg NdPr price-protection agreement took effect. Magnetics turned
segment-EBITDA-positive on schedule in 1H'25.
Annual Financial Summary (FY ends December)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue ($K) | $331,952 | $527,510 | $253,445 | $203,855 | $224,441 |
| Rev YoY | — | +58.9% | -52.0% | -19.6% | +10.1% |
| Operating Income ($K) | $165,345 | $327,411 | ($17,719) | ($169,426) | ($149,374) |
| Adj. EBITDA ($K) | $219,077 | $388,631 | $102,502 | ($50,168) | $11,419 |
| EBITDA YoY | — | +77.4% | -73.6% | n.m. (to loss) | to +$11.4M |
| Adj. Diluted EPS | $0.83 | $1.68 | $0.39 | ($0.44) | ($0.24) |
| Free Cash Flow ($K) | ($17,517) | $22,049 | ($196,398) | ($172,973) | ($303,930) |
| FCF YoY | — | to +$22M | to -$196M | +12.2% | -75.7% |
Free cash flow is negative and worsening — the dominant fact.
FCF was negative in 4 of the last 5 years and all 13 quarters reviewed; 2025's -$303.9M is the
worst on record, with operating cash flow itself turning negative (-$155.8M). The 2021-22
profitability reflects the legacy concentrate-to-China model at peak NdPr pricing and is not
comparable to the current integrated cost structure. This is not positive or growing FCF.
Key trends
- Revenue -- volatile, not cleanly accelerating: Full-year revenue swung from $527.5M (2022 peak) down to $203.9M (2024) and back to $224.4M (2025, +10.1%); Q1'26 reaccelerated to +49% YoY on the NdPr / Magnetics ramp, but two of the last four quarters printed negative YoY
- Gross margin recovering off a deep trough: Bottomed at -32.6% (Q2'24) and climbed ~5,000 bps to +18.1% (Q1'26) -- the one genuinely positive trend
- Operating income negative ten straight quarters: Full-year 2025 still an operating loss of ($149.4M); adjusted EBITDA only turned positive in Q4'25/Q1'26 once the DoW price floor took effect
- Share count diluting, not declining: Period-end basic shares rose from 163.2M (Q4'24) to 177.7M (Q1'26), ~+8.8% YoY on a Q3'25 equity raise -- under the 10% penalty threshold, but the wrong direction for the rubric
Blemishes / Watch Items
| Item | Detail | Penalty |
|---|---|---|
| Negative FCF | Negative every quarter reviewed and 4 of 5 years; record -$303.9M in 2025. Mandatory penalty, caps the dimension at 6 | -2 |
| Revenue up, operating income down | 2025 revenue +10.1% yet ($149.4M) operating loss; Q1'26 revenue +49% YoY but operating income still ($24.1M) | -1 |
| Share dilution | Period-end shares +8.8% YoY on a Q3'25 equity raise -- under the 10% threshold, so no penalty, but the wrong direction | None |
Score Rationale
Score of 3/10 reflects a company clawing out of a 2023-24 trough, still financially unproven against the rubric.
Base score of 5: revenue YoY is volatile/mixed (not stable, not cleanly accelerating); margins are expanding off-trough (gross +5,000 bps but operating still deeply negative); share count is diluting; FCF is declining.
Mandatory penalties applied:
- Negative FCF -2 (hard cap at 6, binding): negative every period, worst-ever -$303.9M in 2025
- Revenue growing but operating income declining -1: 2025 revenue +10.1% yet ($149.4M) operating loss; Q1'26 revenue +49% YoY but operating income still ($24.1M)
- Share dilution >10%: N/A (~8.8%)
5 − 2 − 1 = 3/10. The genuinely encouraging signals -- the gross-margin recovery off a -32.6% trough to +18.1%, NdPr volume doubling to ~1,006 MT and NdPr revenue tripling YoY, early Magnetics profitability, and the Q4'25/Q1'26 adjusted-EBITDA inflection -- are real, but the forward thesis depends on the ramp and price-protection economics converting this margin/EBITDA recovery into actual cash generation, which has not happened yet.
Composite quality gate — positiveGrowingFcf: NO. Free cash flow negative in every period reviewed and worsening; 2025 FCF of ($303.9M) is the worst on record.
Data sourced from Daloopa (company_id 22547). Fiscal year ends December 31. All financials in USD. Q1'23 gross margin above 100% reflects a one-time Shenghe contract true-up; 2021-22 figures reflect the legacy concentrate-to-China model and are not comparable to the current integrated cost structure.